COMMUNIQUÉS West-GlobeNewswire

Alpha Pro Tech, Ltd. Announces Additional $2 Million Expansion to Share Repurchase Program

20/12/2018 - 22:15

NOGALES, Ariz., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Nogales, Arizona – December 20, 2018, Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and [...]

SI-BONE to Present at the 37th Annual J.P. Morgan Healthcare Conference

20/12/2018 - 22:05

SANTA CLARA, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant [...]

ChromaDex Corp. and Nestlé Health Science Enter Global Commercial License and Supply Agreement for TRU NIAGEN®

20/12/2018 - 22:05

ChromaDex Corporation and Nestlé Health Science agreement includes global commercial license and supply agreement for ingredient sales of TRU NIAGEN® for certain products within the medical nutrition and consumer health [...]

ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial

20/12/2018 - 22:01

Phase 3 atrial fibrillation trial planned in population with no effective or FDA approved therapies PRECISION-AF, planned Phase 3 clinical trial in patients with genotype that responds most favorably to Gencaro [...]

Apellis Pharmaceuticals’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of C3 Glomerulopathy

20/12/2018 - 22:01

CRESTWOOD, Ky. and WALTHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. , (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Tetra Successfully Completes Phase 1 Study With Vaporized Version of PPP001

20/12/2018 - 22:00

Planning for Phase 2 Clinical Trial Underway OTTAWA, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or “ TBP ”) today announced that its Phase 1 clinical trial in healthy volunteers using vaporized [...]

Flexion Therapeutics to Report Preliminary Unaudited 2018 Revenue and Provide 2019 Revenue Guidance on January 3, 2019

20/12/2018 - 22:00

BURLINGTON, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) will announce preliminary unaudited revenue for the fourth-quarter and full-year 2018 and provide revenue guidance for 2019 [...]

Gritstone Oncology Announces FDA Fast Track Designation for GRANITE-001 for the Treatment of Colorectal Cancer

20/12/2018 - 22:00

EMERYVILLE, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]

Corizon Health to Partner With the State of Maryland

20/12/2018 - 21:31

Transition to occur New Year’s Day BRENTWOOD, Tenn., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Corizon Health will be ringing in the New Year with a contract to provide inmate healthcare services to the State of Maryland. The [...]

GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Positive Panel

20/12/2018 - 20:15

CARLSBAD, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has received FDA 510( [...]

Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

20/12/2018 - 19:34

CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]

With Strategic Investment, Westleaf Expands Retail Footprint -- CFN Media

20/12/2018 - 19:10

SEATTLE, WA, Dec. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]

OSE Immunotherapeutics Announces First Healthy Volunteers Dosed in Phase 1 Clinical Trial of OSE-127

20/12/2018 - 18:00

Entry into clinical phase of this anti-IL-7 receptor antagonist A breakthrough approach for the treatment of inflammatory autoimmune diseases NANTES, France, Dec. 20, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA ( [...]

Iba sa: Transparency notification

20/12/2018 - 17:35

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, December 20, 2018, 17.35 - IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

IBA SA: Notification de transparence

20/12/2018 - 17:35

IBA – NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 20 décembre 2018, 17.35 – IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, [...]

Novartis announces offer to acquire CellforCure to expand manufacturing capacity for innovative cell and gene therapies

20/12/2018 - 17:01

Proposed acquisition builds on existing agreement with CellforCure for contract manufacturing of Novartis leading CAR-T cell therapy Kymriah ® (tisagenlecleucel) and recent successful completion of technology transfer [...]

RUDDCO Inc. Announces the Start of Operations in the Cranbrook Botanical Garden

20/12/2018 - 16:00

MIAMI, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Ruddco Inc., a Florida-based company, in conjunction with Orange Hill Limited under a joint venture agreement is announcing an expansion of cannabis operations and the opening of [...]

Endocyte Stockholders Approve Merger Agreement with Novartis AG

20/12/2018 - 15:25

WEST LAFAYETTE, Ind., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) (“Endocyte”), a biopharmaceutical company developing targeted therapeutics for cancer treatment, today announced that at its Special [...]

The Financial Calendar of JSC “Grindeks” for the year of 2019

20/12/2018 - 15:05

JSC "Grindeks" plans to publish its: non-audited interim financial statement for the 12-month period of 2018 on 28 February 2019; non-audited interim financial statement for the 3-month period of 2019 on 30 May 2019; [...]